We are live on
!
Find out more
CC
Colrain Capital Portfolio holdings
AUM
$259M
1-Year Est. Return
63.6%
This Fund
S&P 500
This Quarter
Est. Return
+9.44%
1 Year Est. Return
+63.6%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$117M
AUM Growth
+$15.1M
(+15%)
Cap. Flow
+$8.76M
Cap. Flow
% of AUM
7.48%
Top 10 Holdings %
Top 10 Hldgs %
68.3%
Holding
27
New
–
Increased
17
Reduced
5
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$3.64M |
| 2 |
SLB Ltd
SLB
|
+$3.48M |
| 3 |
Cigna
CI
|
+$1.17M |
| 4 |
CVS Health
CVS
|
+$1M |
| 5 |
Comcast
CMCSA
|
+$902K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Agnico Eagle Mines
AEM
|
+$1.82M |
| 2 |
Microsoft
MSFT
|
+$1.46M |
| 3 |
Apple
AAPL
|
+$1.11M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$875K |
| 5 |
Vistra
VST
|
+$710K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.63% |
| 2 | Energy | 20.55% |
| 3 | Materials | 15.87% |
| 4 | Technology | 11.17% |
| 5 | Utilities | 9.72% |
Similar funds
NAM
CCAM
QP
PW
BFP
TC
FC
GWM
Colrain Capital's Q1 2025 Portfolio in Review
As of Q1 2025, Colrain Capital held 27 positions worth $117M, up 15% from $102M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Colrain Capital deployed $8.76M of net new capital in Q1 2025, adding to 17 existing holdings.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 19% a quarter earlier, followed by Energy and Materials.
On the sell side, the largest reduction was Apple, an estimated $1.11M trimmed.
- Colrain Capital added most to Newmont in Q1 2025, an estimated $3.64M increase.
- Colrain Capital's biggest Q1 2025 reduction was Apple, cutting an estimated $1.11M.
- Colrain Capital fully exited Agnico Eagle Mines in Q1 2025, selling an estimated $1.82M.
- Colrain Capital's ten largest holdings make up 68% of its $117M portfolio in Q1 2025.
- Colrain Capital opened 0 new positions and closed 3 in Q1 2025.
- Colrain Capital's portfolio value rose 15% quarter-over-quarter to $117M.
Based on Colrain Capital's 13F filing for Q1 2025, filed 12 May 2025.